Genomic Health, Inc., now part of Exact Sciences, is a life science company specializing in the development and commercialization of genomic-based clinical diagnostic tests for cancer. The company provides diagnostic services that offer critical information on the likelihood of disease recurrence and response to specific therapies, aiming to guide personalized treatment plans. Their market focus is on early cancer detection and prevention, leveraging advanced genomic technologies to improve patient outcomes.
Genomic Health has made significant strides in the field of cancer diagnostics, contributing to earlier and more accurate detection of various cancers. Their innovative tests have become integral tools for oncologists, aiding in the formulation of personalized treatment strategies. The company's impactful work has garnered attention and investment from notable figures in the healthcare and biotech industries, solidifying its reputation as a leader in genomic-based diagnostics.